<p>Time from start to completion (A) and from completion to publication (B) for 2009 H1N1 vaccine trials.</p
<p>Major outcomes through 60 days of follow-up for A(H1N1)pdm09-infected patients enrolled in FLU003...
<p>Time (days) to seroconversion for all badgers that seroconverted during the trial: non-vaccinated...
<p>(A) Among 104 healthcare workers who reported receipt of pandemic (H1N1) 2009 vaccine, the propor...
<p>Time from start to publication for 2009 H1N1 vaccine trials overall (A) and according to sponsor ...
<p>Cumulative sample size in launched and published trials of 2009 H1N1 vaccines over time.</p
<p>Time to influenza diagnosis according to vaccination date of HCWs and respective workplaces.</p
Randomized evidence for vaccine immunogenicity and safety is urgently needed in the setting of pande...
<p>The H1N1 positive tests reported to the CDC in the United States from April 24, 2009 (week 17) to...
<p>Time after the onset of fever and the number of patients who were diagnosed by the RT-SmartAmp as...
<p>1. Prescription (ATC) and diagnosis (ICD10) history before index date (MSLT-referral date). Ever ...
Background: Randomized evidence for vaccine immunogenicity and safety is urgently needed in the sett...
BACKGROUND: Randomized evidence for vaccine immunogenicity and safety is urgently needed in the sett...
<p>A chronology of events about the pH1N1vaccine availability, reporting of potential vaccine-relate...
<p>Length of time taken after start date for trial registration to be created for trials that were r...
The earliest time at which serum antibody levels peak following administration of an influenza virus...
<p>Major outcomes through 60 days of follow-up for A(H1N1)pdm09-infected patients enrolled in FLU003...
<p>Time (days) to seroconversion for all badgers that seroconverted during the trial: non-vaccinated...
<p>(A) Among 104 healthcare workers who reported receipt of pandemic (H1N1) 2009 vaccine, the propor...
<p>Time from start to publication for 2009 H1N1 vaccine trials overall (A) and according to sponsor ...
<p>Cumulative sample size in launched and published trials of 2009 H1N1 vaccines over time.</p
<p>Time to influenza diagnosis according to vaccination date of HCWs and respective workplaces.</p
Randomized evidence for vaccine immunogenicity and safety is urgently needed in the setting of pande...
<p>The H1N1 positive tests reported to the CDC in the United States from April 24, 2009 (week 17) to...
<p>Time after the onset of fever and the number of patients who were diagnosed by the RT-SmartAmp as...
<p>1. Prescription (ATC) and diagnosis (ICD10) history before index date (MSLT-referral date). Ever ...
Background: Randomized evidence for vaccine immunogenicity and safety is urgently needed in the sett...
BACKGROUND: Randomized evidence for vaccine immunogenicity and safety is urgently needed in the sett...
<p>A chronology of events about the pH1N1vaccine availability, reporting of potential vaccine-relate...
<p>Length of time taken after start date for trial registration to be created for trials that were r...
The earliest time at which serum antibody levels peak following administration of an influenza virus...
<p>Major outcomes through 60 days of follow-up for A(H1N1)pdm09-infected patients enrolled in FLU003...
<p>Time (days) to seroconversion for all badgers that seroconverted during the trial: non-vaccinated...
<p>(A) Among 104 healthcare workers who reported receipt of pandemic (H1N1) 2009 vaccine, the propor...
DOI
Add to ORKG